18 employees
Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.
2019
$50M
from 1 investors over 1 rounds
Baudax Bio raised $50M on June 1, 2020
Investors: Marathon Asset Management